CS logo
small CS logo
Royal Bournemouth Hospital - Haematology

Bournemouth, United Kingdom
Hospital department in Bournemouth, England
Castle Ln E, Bournemouth BH7 7DW

About Royal Bournemouth Hospital - Haematology


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
3
Celgene
2
Celgene Corporation
1
Total Rows: 3

Clinical Trials at Royal Bournemouth Hospital - Haematology


During the past decade, Royal Bournemouth Hospital - Haematology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety Study of CC-5013 Monotherapy in Subjects With Myelodysplastic Syndromes
2003-06-01
2007-02-01
Completed
215
FCR Versus FC Alone in the Treatment of Chronic Lymphocytic Leukemia (CLL) in Relapsed Patients
2003-07-31
2012-05-31
Completed
552
Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)
2010-09-02
2018-04-05
Completed
111
Study to Evaluate the Safety and Efficacy of Pomalidomide Monotherapy in Subjects With Refractory or Relapsed Refractory Multiple Myeloma
2011-03-01
2014-07-31
Completed
74
A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)
2011-07-06
2021-07-30
Completed
1,401
A Study Comparing Maintenance Subcutaneous Rituximab With Observation Only in Participants With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma Who Had Responded to Rituximab-based Immunochemotherapy Induction and 2-year Maintenance With Subcutaneous Rituximab
2011-12-20
2018-06-02
Completed
692

Rows per page:

1–6 of 6

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Bournemouth Hospital - Haematology" #1 collaborator was "Biogen" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "German Low Grade Lymphoma Study Group" with 1 trials as a collaborator and "Institute of Cancer Research, United Kingdom" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 3Hoffmann-La Roche: 3Celgene: 2Celgene: 2Celgene Corporation: 1Celgene Corporation: 1

Created with Highcharts 11.1.0Top CollaboratorsBiogen: 1Biogen: 1Genentech, Inc.: 1Genentech, Inc.: 1German Low GradeLymphoma StudyGroup: 1German Low GradeLymphoma StudyGroup: 1Institute of CancerResearch, UnitedKingdom: 1Institute of CancerResearch, UnitedKingdom: 1

Clinical Trials Conditions at Royal Bournemouth Hospital - Haematology


According to Clinical.Site data, the most researched conditions in "Royal Bournemouth Hospital - Haematology" are "Non-Hodgkin's Lymphoma" (2 trials), "Chronic Lymphocytic Leukemia" (1 trials), "Diffuse Large B-cell Lymphoma" (1 trials), "Multiple Myeloma" (1 trials) and "Myelodysplastic Syndromes" (1 trials). Many other conditions were trialed in "Royal Bournemouth Hospital - Haematology" in a lesser frequency.

Clinical Trials Intervention Types at Royal Bournemouth Hospital - Haematology


Most popular intervention types in "Royal Bournemouth Hospital - Haematology" are "Drug" (6 trials). Other intervention types were less common.
The name of intervention was led by "Rituximab" (4 trials), "Cyclophosphamide" (2 trials), "Bendamustine" (1 trials), "CC-5013" (1 trials) and "Chemotherapy (Induction Period)" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Royal Bournemouth Hospital - Haematology


The vast majority of trials in "Royal Bournemouth Hospital - Haematology" are 6 trials for "All" genders.

Clinical Trials Status at Royal Bournemouth Hospital - Haematology


Currently, there are NaN active trials in "Royal Bournemouth Hospital - Haematology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Royal Bournemouth Hospital - Haematology, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Royal Bournemouth Hospital - Haematology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 5Phase 3: 5Phase 2: 2Phase 2: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 6Completed: 6